Project-specific health-based exposure limit and occupational toxicology assessment support. The agreed scope may include PDE/ADE derivation, OEL derivation and OEB/OHC banding, based on the exact substance form, available evidence and intended product or workplace context.
CAS Registry Number
76-38-0
Molecular formula
C3H4Cl2F2O
Molecular weight
164.96 g/mol
Drug class
Volatile fluorinated hydrocarboninhaled analgesic
Mechanism of action
The precise analgesic mechanism is not fully elucidated. At low inhaled concentrations, methoxyflurane acts through multiple neuronal mechanisms, including effects on neurotransmitter release and uptake, ion conductance and inhibitory GABA signalling.
Indications / reported uses
Emergency relief of moderate-to-severe pain in conscious patients aged 6 years and older with trauma and associated pain, using the authorised inhaler product.
Scope is agreed for the exact substance form, intended use, exposure route, workplace context and available toxicological evidence.
PDE/ADE: critical effects, point of departure and justified adjustment factors.
OEL: inhalation hazards, exposure duration and workplace conditions.
OEB/OHC: evidence-based banding where requested; a band is not a numerical OEL.
Report: scientific rationale, source data, assumptions, uncertainties and limitations.
Assessment scope
PDE/ADE and OEL/OEB assessment
ReguSight provides project-specific support for Methoxyflurane PDE/ADE, OEL and OEB/OHC assessments. This combined profile covers the Methoxyflurane Permitted Daily Exposure (PDE) report (the Methoxyflurane PDE report); Acceptable Daily Exposure (ADE) is the corresponding health-based daily exposure terminology. It also covers the Methoxyflurane Occupational Exposure Limit (OEL) report (the Methoxyflurane OEL report). PDE/ADE derivation and workplace exposure assessment are distinct scientific outputs; a band is not a numerical OEL.
Assessment may cover
PDE/ADE derivation using relevant toxicological evidence, critical effects, a justified point of departure and adjustment factors.
The EMA HBEL guideline informs PDE/ADE assessments in relevant shared-facility contexts. ECHA and HSE sources address workplace exposure limits; NIOSH provides occupational exposure-banding guidance. The applicable framework depends on the assessment question and jurisdiction.